| 1. |
Updated cholesterol guideline leads to more aggressive therapy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
A new report*by the World Bank suggests that a mere 2% of the 555 000 individuals with AIDS in India receive antiretroviral therapy, reports theBMJ. |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Pharmacoeconomic news from the 15th International AIDS Conference |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 4-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Early initiation of irbesartan provides maximum cost benefits |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Second-generation triptans a better option for migraine? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Vibriolysin [Vibrilase]*is well tolerated and demonstrates efficacy as a debriding agent for serious burns, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
The combination of tenofovir disoproxil fumarate [TDF, Viread] plus emtricitabine [Emtriva] is superior to lamivudine plus zidovudine [Combivir] in treatment-naive patients with HIV, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Gemcitabine boosts paclitaxel efficacy in metastatic breast cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 9-10
C Innes,
Preview
|
|
摘要:
First-line therapy with gemcitabine plus paclitaxel improves overall survival, compared with paclitaxel alone, in patients with metastatic breast cancer who have been previously treated with anthracyclines, according to a study presented at the 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) [New Orleans, US; June 2004]. The combination regimen has previously been shown to significantly improve time to progression and overall response rate. Those results, and these latest interim survival data led to the FDA approval of gemcitabine in combination with paclitaxel for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, effective May 2004.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
Epirubicin plus vinorelbine useful in advanced breast cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
A novel short melarsoprol treatment regimen has comparable long-term efficacy to the standard regimen in patients with late-stage African trypanosomiasis, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1453,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
